Lilly Just Placed Million Bet on Injectables Boom
Lilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
Learn how to verify that automatic index fund contributions are set up correctly, with simple steps to confirm schedules, amounts, and fund targets.
14,470 articlesLilly is backing Absci with a $40 million investment as Absci advances ABS-201, a next-gen injectable targeting hair ...
As conflicts persist around the globe, households feel the bill. Experts say the true cost goes beyond weapons, shapi...
McDonald’s raised its quarterly dividend again as franchisees contend with higher costs and softer consumer demand. T...
A new study links early retirement with faster cognitive decline, urging Gen X to stay in the workforce longer. Econo...
Famed investor Michael Burry reportedly tacks a bearish stance onto Micron Technology, signaling renewed caution for ...
Bloom Energy has drawn big investor attention after a dramatic rally. This guide breaks down what the company does, w...
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Investors are buzzing about a SpaceX and TESLA merger. This piece dives into what a deal could mean for AI, energy, a...
Netflix has fallen sharply, but a trough like this can hide opportunity. This guide breaks down what drove the declin...
The summer months offer a quiet window to recalibrate your retirement income plan. Learn practical, actionable steps ...
Meta Platforms and CoreWeave reported sharply different Q1 2026 results, highlighting Meta’s cash-flow machine and Co...
Novo Nordisk faces challenges, but three strong catalysts could propel the stock higher. This article breaks down the...